You have 9 free searches left this month | for more free features.

T-Reg

Showing 26 - 50 of 8,883

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

Completed
  • Ulcerative Colitis
    • Calgary, Alberta, Canada
    • +22 more
    Jan 22, 2021

    Chronicrhinosinusitis Without Nasalpolyps, Sinusitis, Chronic Sinusitis Trial in Worldwide (Dupilumab SAR231893, Placebo)

    Recruiting
    • Chronicrhinosinusitis Without Nasalpolyps
    • +4 more
    • Dupilumab SAR231893
    • Placebo
    • Roseville, California
    • +49 more
    May 3, 2022

    Kidney Failure, Kidney Transplant Trial in Boston (T Regulatory Cell Infusion)

    Completed
    • Kidney Failure, Kidney Transplant
    • T Regulatory Cell Infusion
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 15, 2021

    Type2 Diabetes Trial in Herlev (Empagliflozin, Placebo Oral Tablet)

    Completed
    • Type2 Diabetes Mellitus
    • Herlev, Denmark
      Herlev og Gentofte Hospital
    Aug 17, 2022

    COVID-19 Trial in Worldwide (Standard of care, Apremilast, Apremilast )

    Completed
    • COVID-19
    • Standard of care
    • +6 more
    • Anniston, Alabama
    • +58 more
    Jun 23, 2022

    Neuroendocrine Tumors Trial in Napoli (Octreotide Acetate)

    Completed
    • Neuroendocrine Tumors
    • Octreotide Acetate
    • Napoli, Italy
      Istitute Nazionale Tumori - Fondazione G. Pascale
    Sep 9, 2020

    Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (satralizumab, azathioprine (AZA), mycophenolate mofetil (MMF))

    Active, not recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • Birmingham, Alabama
    • +52 more
    Mar 16, 2022

    The Temporal Cellular Landscape of Adaptive Immune System in

    Recruiting
    • Stroke, Acute
      • Amsterdam, Noord-Holland, Netherlands
        Academic University Medical Center Amsterdam
      Apr 16, 2021

      Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

      Recruiting
      • Anatomic Stage I Breast Cancer AJCC v8
      • +6 more
      • Biopsy
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Jan 6, 2023

      Systemic Sclerosis Trial (Autologous Regulatory ?-cells, Standard treatment according to the clinical protocols)

      Not yet recruiting
      • Systemic Sclerosis
      • Autologous Regulatory ΠΆ-cells
      • Standard treatment according to the clinical protocols
      • (no location specified)
      Jan 25, 2022

      Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

      Recruiting
      • Advanced Colorectal Carcinoma
      • +15 more
      • Fermented Wheat Germ Extract
      • Sacramento, California
        University of California Davis Comprehensive Cancer Center
      Jul 26, 2023

      Hemophilia A Trial in Worldwide (PEGylated Recombinant Factor VIII, ITI)

      Recruiting
      • Hemophilia A
      • PEGylated Recombinant Factor VIII
      • ITI
      • Phoenix, Arizona
      • +91 more
      Jul 30, 2021

      Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)

      Completed
      • Leukemia
      • Lymphoma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Jan 6, 2021

      Non Small Cell Lung Cancer Trial in Los Angeles (Apricoxib)

      Terminated
      • Non Small Cell Lung Cancer
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center
      Sep 21, 2020

      Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester

      Not yet recruiting
      • Clinical Stage IV Gastric Cancer AJCC v8
      • +4 more
      • Aldesleukin
      • +10 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Apr 5, 2023

      Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

      Recruiting
      • Myeloid Leukemia, Chronic
      • +8 more
      • Conventional T cells (Tcon) and Regulatory T cells (Treg)
      • Palo Alto, California
        Stanford University School of Medicine Palo Alto, California, Un
      Aug 18, 2021

      Rectal Cancer Trial in Australia, New Zealand (TG02-treatment, Pembrolizumab)

      Terminated
      • Rectal Cancer
      • Brisbane, Australia
      • +3 more
      Nov 17, 2021

      Chronic Pain, Neuropathic Pain, Complex Regional Pain Syndromes Trial (Stellate Ganglion Block (SGB), Thoracic Sympathetic

      Not yet recruiting
      • Chronic Pain
      • +4 more
      • Stellate Ganglion Block (SGB)
      • Thoracic Sympathetic Ganglion Block (TSGB)
      • (no location specified)
      Nov 8, 2023

      GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose

      Terminated
      • Graft Versus Host Disease
      • Cyclophosphamide and Sirolimus
      • +3 more
      • Hackensack, New Jersey
        John Theurer Cancer Center at Hackensack University Medical Cent
      Feb 4, 2022

      Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Antihistamine, Methylprednisolone)

      Recruiting
      • Multiple Sclerosis
      • Cullman, Alabama
      • +202 more
      Jan 27, 2023

      Amyotrophic Lateral Sclerosis Trial in Italy, United States (RNS60)

      Completed
      • Amyotrophic Lateral Sclerosis
      • Boston, Massachusetts
      • +22 more
      Nov 5, 2021

      Noninvasive Monitoring of Cerebral Blood Flow Autoregulation

      Completed
      • Intracranial Pressure Increase
      • Cerebral Edema
        • New Orleans, Louisiana
          Ochsner Health System
        Dec 8, 2021

        Venous Thromboembolism, Secondary Prevention Trial in Worldwide (dabigatran etexilate)

        Completed
        • Venous Thromboembolism
        • Secondary Prevention
        • dabigatran etexilate
        • Sacramento, California
        • +61 more
        May 29, 2020

        HIV-1-infection Trial (FMT capsules, Placebo capsules)

        Not yet recruiting
        • HIV-1-infection
        • FMT capsules
        • Placebo capsules
        • (no location specified)
        Aug 31, 2023